Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
Trobajo-Sanmartín C, Martínez-Baz I, Miqueleiz A, Fernández-Huerta M, Burgui C, Casado I, Baigorría F, Navascués A, Castilla J, Ezpeleta C. Trobajo-Sanmartín C, et al. Among authors: baigorria f. Microbiol Spectr. 2022 Apr 27;10(2):e0000822. doi: 10.1128/spectrum.00008-22. Epub 2022 Apr 12. Microbiol Spectr. 2022. PMID: 35412379 Free PMC article.
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
Martínez-Baz I, Miqueleiz A, Casado I, Navascués A, Trobajo-Sanmartín C, Burgui C, Guevara M, Ezpeleta C, Castilla J; Working Group for the Study of COVID-19 in Navarra. Martínez-Baz I, et al. Euro Surveill. 2021 May;26(21):2100438. doi: 10.2807/1560-7917.ES.2021.26.21.2100438. Euro Surveill. 2021. PMID: 34047271 Free PMC article.
Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study.
Castilla J, Guevara M, Miqueleiz A, Baigorria F, Ibero-Esparza C, Navascués A, Trobajo-Sanmartín C, Martínez-Baz I, Casado I, Burgui C, Ezpeleta C, The Working Group For The Study Of Covid-In Navarra. Castilla J, et al. Among authors: baigorria f. J Clin Med. 2021 Jun 13;10(12):2608. doi: 10.3390/jcm10122608. J Clin Med. 2021. PMID: 34199198 Free PMC article.
Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021.
Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Guevara M, Fernández-Huerta M, Burgui C, Casado I, Portillo ME, Navascués A, Ezpeleta C, Castilla J; Working Group for the Study of COVID-19 in Navarre; Investigators, other members of the Working Group for the Study of COVID-19 in Navarre. Martínez-Baz I, et al. Euro Surveill. 2021 Sep;26(39):2100894. doi: 10.2807/1560-7917.ES.2021.26.39.2100894. Euro Surveill. 2021. PMID: 34596016 Free PMC article.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Kissling E, Hooiveld M, Sandonis Martín V, Martínez-Baz I, William N, Vilcu AM, Mazagatos C, Domegan L, de Lusignan S, Meijer A, Machado A, Brytting M, Casado I, Murray JK, Belhillil S, Larrauri A, O'Donnell J, Tsang R, de Lange M, Rodrigues AP, Riess M, Castilla J, Hamilton M, Falchi A, Pozo F, Dunford L, Cogdale J, Jansen T, Guiomar R, Enkirch T, Burgui C, Sigerson D, Blanchon T, Martínez Ochoa EM, Connell J, Ellis J, van Gageldonk-Lafeber R, Kislaya I, Rose AM, Valenciano M; I-MOVE-COVID-19 primary care study team; I-MOVE-COVID-19 primary care study team (in addition to authors above). Kissling E, et al. Euro Surveill. 2021 Jul;26(29):2100670. doi: 10.2807/1560-7917.ES.2021.26.29.2100670. Euro Surveill. 2021. PMID: 34296676 Free PMC article.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Kissling E, Hooiveld M, Martínez-Baz I, Mazagatos C, William N, Vilcu AM, Kooijman MN, Ilić M, Domegan L, Machado A, de Lusignan S, Lazar M, Meijer A, Brytting M, Casado I, Larrauri A, Murray JK, Behillil S, de Gier B, Mlinarić I, O'Donnell J, Rodrigues AP, Tsang R, Timnea O, de Lange M, Riess M, Castilla J, Pozo F, Hamilton M, Falchi A, Knol MJ, Kurečić Filipović S, Dunford L, Guiomar R, Cogdale J, Cherciu C, Jansen T, Enkirch T, Basile L, Connell J, Gomez V, Sandonis Martín V, Bacci S, Rose AM, Pastore Celentano L, Valenciano M; I-MOVE-COVID-19 and ECDC primary care study teams; I-MOVE-COVID-19 and ECDC primary care study team (in addition to authors above). Kissling E, et al. Euro Surveill. 2022 May;27(21):2101104. doi: 10.2807/1560-7917.ES.2022.27.21.2101104. Euro Surveill. 2022. PMID: 35620997 Free PMC article.
Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Casado I, Navascués A, Burgui C, Ezpeleta C, Castilla J, Guevara M; Working Group for the Study of COVID-19 in Navarra; Members of the Working Group for the Study of COVID-19 in Navarra. Martínez-Baz I, et al. Euro Surveill. 2023 Feb;28(5):2200337. doi: 10.2807/1560-7917.ES.2023.28.5.2200337. Euro Surveill. 2023. PMID: 36729113 Free PMC article.